Page last updated: 2024-08-23

desogestrel and Coronary Disease

desogestrel has been researched along with Coronary Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahlen, GH; Erkkola, R; Porkka, KV; Raitakari, OT; Taimela, S; Viikari, JS1
Shoupe, D1
Graff-Iversen, S; Stensvold, I; Tverdal, A1
Laurendeau, L1
Bennink, HC; Mascarenhas, L; Newton, J; van Beek, A1
Chaikittisilpa, S; Dusitsin, N; Limpaphayom, K; Ninlagarn, T; Panyakhamlerd, K; Taechakraichana, N1
Bijaoui, S; Dupont, G; Foulon, T; Groslambert, P; Laporte, F; Payen, N; Roland, F1

Reviews

2 review(s) available for desogestrel and Coronary Disease

ArticleYear
Effects of desogestrel on carbohydrate metabolism.
    American journal of obstetrics and gynecology, 1993, Volume: 168, Issue:3 Pt 2

    Topics: Animals; Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Female; Humans; Insulin; Insulin Resistance; Male; Risk Factors

1993
[Desogestrel contraceptives: the perfect pill for lipids?].
    Canadian family physician Medecin de famille canadien, 1996, Volume: 42

    Topics: Bias; Cholesterol; Clinical Trials as Topic; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Female; Humans; Lipoproteins; Research Design

1996

Trials

3 trial(s) available for desogestrel and Coronary Disease

ArticleYear
Twenty-four month comparison of apolipoproteins A-1, A-II and B in contraceptive implant users (Norplant and Implanon) in Birmingham, United Kingdom.
    Contraception, 1998, Volume: 58, Issue:4

    Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Contraceptive Agents, Female; Coronary Disease; Desogestrel; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Risk Factors; Socioeconomic Factors; United Kingdom; Vinyl Compounds

1998
A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women.
    Obstetrics and gynecology, 2000, Volume: 95, Issue:1

    Topics: Adult; Bone Density; Contraceptives, Oral; Coronary Disease; Desogestrel; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Medrogestone; Middle Aged; Postmenopause; Progesterone Congeners; Risk Factors

2000
Effects of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serum lipids and lipoproteins with particular regard to LDL size.
    Contraception, 2001, Volume: 64, Issue:1

    Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins

2001

Other Studies

2 other study(ies) available for desogestrel and Coronary Disease

ArticleYear
Influence of oral contraceptive use on lipoprotein (a) and other coronary heart disease risk factors.
    Annals of medicine, 1995, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Analysis of Variance; Cohort Studies; Contraceptives, Oral; Coronary Disease; Desogestrel; Female; Humans; Levonorgestrel; Life Style; Lipoprotein(a); Lipoproteins; Radioimmunoassay; Risk Factors; Smoking

1995
Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening 1985-88.
    Contraception, 1996, Volume: 53, Issue:6

    Topics: Adult; Blood Pressure; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Estradiol; Female; Health Surveys; Humans; Levonorgestrel; Lipids; Lynestrenol; Middle Aged; Norethindrone; Norway; Progesterone Congeners; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires

1996